Lipocine Inc (NASDAQ:LPCN) has announced that the US District Court of Delaware, has accepted the company’s motion and dismissed the lawsuit, filed by Clarus Therapeutics Inc. The company had been accused by Clarus, for patent infringement, in LPCN1021, an oral testosterone product. Dr. Mahesh Patel, the CEO of Lipocine, expressed his pleasure at the court’s […]
EmailWire Instagram
This error message is only visible to WordPress admins
Error: No connected account.
Please go to the Instagram Feed settings page to connect an account.